View in EDS

Valproic acid targets IDH1 mutants through alteration of lipid metabolism.

Saved in:
Bibliographic Details
Title: Valproic acid targets IDH1 mutants through alteration of lipid metabolism.
Authors: Elahi LS; Department of Psychiatry and Behavioral Sciences and the UCLA Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine, UCLA, Los Angeles, CA USA., Condro MC; Department of Psychiatry and Behavioral Sciences and the UCLA Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine, UCLA, Los Angeles, CA USA., Kawaguchi R; Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA USA., Qin Y; Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA USA., Alvarado AG; Department of Psychiatry and Behavioral Sciences and the UCLA Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine, UCLA, Los Angeles, CA USA., Gruender B; Department of Psychiatry and Behavioral Sciences and the UCLA Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine, UCLA, Los Angeles, CA USA., Qi H; Department of Psychiatry and Behavioral Sciences and the UCLA Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine, UCLA, Los Angeles, CA USA., Li T; Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA USA., Lai A; Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA USA., Castro MG; Department of Neurosurgery, Department of Cell and Developmental Biology, and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI USA., Lowenstein PR; Department of Neurosurgery, Department of Cell and Developmental Biology, and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI USA., Garrett MC; Kettering Health Network, Kettering, OH USA., Kornblum HI; Department of Psychiatry and Behavioral Sciences and the UCLA Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine, UCLA, Los Angeles, CA USA.; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, CA USA.
Source: Npj metabolic health and disease [NPJ Metab Health Dis] 2024; Vol. 2 (1), pp. 20. Date of Electronic Publication: 2024 Aug 13.
Publication Type: Journal Article
Journal Info: Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918751588706676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2948-2828 (Electronic) Linking ISSN: 29482828 NLM ISO Abbreviation: NPJ Metab Health Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39149696
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Valproic acid targets IDH1 mutants through alteration of lipid metabolism.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Elahi+LS%22">Elahi LS</searchLink>; Department of Psychiatry and Behavioral Sciences and the UCLA Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine, UCLA, Los Angeles, CA USA.<br /><searchLink fieldCode="AU" term="%22Condro+MC%22">Condro MC</searchLink>; Department of Psychiatry and Behavioral Sciences and the UCLA Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine, UCLA, Los Angeles, CA USA.<br /><searchLink fieldCode="AU" term="%22Kawaguchi+R%22">Kawaguchi R</searchLink>; Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA USA.<br /><searchLink fieldCode="AU" term="%22Qin+Y%22">Qin Y</searchLink>; Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA USA.<br /><searchLink fieldCode="AU" term="%22Alvarado+AG%22">Alvarado AG</searchLink>; Department of Psychiatry and Behavioral Sciences and the UCLA Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine, UCLA, Los Angeles, CA USA.<br /><searchLink fieldCode="AU" term="%22Gruender+B%22">Gruender B</searchLink>; Department of Psychiatry and Behavioral Sciences and the UCLA Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine, UCLA, Los Angeles, CA USA.<br /><searchLink fieldCode="AU" term="%22Qi+H%22">Qi H</searchLink>; Department of Psychiatry and Behavioral Sciences and the UCLA Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine, UCLA, Los Angeles, CA USA.<br /><searchLink fieldCode="AU" term="%22Li+T%22">Li T</searchLink>; Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA USA.<br /><searchLink fieldCode="AU" term="%22Lai+A%22">Lai A</searchLink>; Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA USA.<br /><searchLink fieldCode="AU" term="%22Castro+MG%22">Castro MG</searchLink>; Department of Neurosurgery, Department of Cell and Developmental Biology, and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI USA.<br /><searchLink fieldCode="AU" term="%22Lowenstein+PR%22">Lowenstein PR</searchLink>; Department of Neurosurgery, Department of Cell and Developmental Biology, and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI USA.<br /><searchLink fieldCode="AU" term="%22Garrett+MC%22">Garrett MC</searchLink>; Kettering Health Network, Kettering, OH USA.<br /><searchLink fieldCode="AU" term="%22Kornblum+HI%22">Kornblum HI</searchLink>; Department of Psychiatry and Behavioral Sciences and the UCLA Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine, UCLA, Los Angeles, CA USA.; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, CA USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918751588706676%22">Npj metabolic health and disease</searchLink> [NPJ Metab Health Dis] 2024; Vol. 2 (1), pp. 20. <i>Date of Electronic Publication: </i>2024 Aug 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Portfolio%22">Nature Portfolio </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9918751588706676 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2948-2828 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2229482828%22">29482828 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Metab Health Dis <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39149696
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s44324-024-00021-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 20
    Titles:
      – TitleFull: Valproic acid targets IDH1 mutants through alteration of lipid metabolism.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Elahi LS
      – PersonEntity:
          Name:
            NameFull: Condro MC
      – PersonEntity:
          Name:
            NameFull: Kawaguchi R
      – PersonEntity:
          Name:
            NameFull: Qin Y
      – PersonEntity:
          Name:
            NameFull: Alvarado AG
      – PersonEntity:
          Name:
            NameFull: Gruender B
      – PersonEntity:
          Name:
            NameFull: Qi H
      – PersonEntity:
          Name:
            NameFull: Li T
      – PersonEntity:
          Name:
            NameFull: Lai A
      – PersonEntity:
          Name:
            NameFull: Castro MG
      – PersonEntity:
          Name:
            NameFull: Lowenstein PR
      – PersonEntity:
          Name:
            NameFull: Garrett MC
      – PersonEntity:
          Name:
            NameFull: Kornblum HI
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2948-2828
          Numbering:
            – Type: volume
              Value: 2
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Npj metabolic health and disease
              Type: main
ResultId 1